We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$391M
AUM Growth
+$24.9M
Cap. Flow
+$6.5M
Cap. Flow %
1.66%
Top 10 Hldgs %
24.49%
Holding
285
New
24
Increased
110
Reduced
87
Closed
16
Avg Time Held Equity + Options
14 quarters
Top 10 Avg Time Held Equity + Options
10.8 quarters
Top 20 Avg Time Held Equity + Options
12.8 quarters
Avg Time Held Equity only
14 quarters
Top 10 Avg Time Held Equity only
10.8 quarters
Top 20 Avg Time Held Equity only
12.8 quarters

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.14M
2
META icon
Meta Platforms (Facebook)
META
+$1.99M
3
NVDA icon
NVIDIA
NVDA
+$1.87M
4
AMZN icon
Amazon
AMZN
+$1.54M
5
GILD icon
Gilead Sciences
GILD
+$1.47M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.37%
2 Technology 20.82%
3 Consumer Discretionary 13.26%
4 Financials 10.08%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HSY icon
101
Hershey
HSY
$32.8B
$1.13M 0.29%
5,875
+590
+11% +$115K
2023 Q4
3 quarters
TREE icon
102
LendingTree
TREE
$348M
$1.12M 0.29%
19,375
+7,125
+58% +$368K
2023 Q2
5 quarters
EMB icon
103
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13B
$1.12M 0.29%
11,983
-185
-2% -$16.9K
2024 Q1
2 quarters
SBUX icon
104
Starbucks
SBUX
$105B
$1.11M 0.28%
11,430
+984
+9% +$84.4K
2016 Q4
31 quarters
REGN icon
105
Regeneron Pharmaceuticals
REGN
$77.5B
$1.11M 0.28%
1,055
– –
2016 Q4
31 quarters
HD icon
106
Home Depot
HD
$293B
$1.11M 0.28%
2,732
-495
-15% -$181K
2016 Q4
31 quarters
IBM icon
107
IBM
IBM
$217B
$1.1M 0.28%
4,953
+158
+3% +$31K
2024 Q1
2 quarters
IOVA icon
108
Iovance Biotherapeutics
IOVA
$6.57B
$1.06M 0.27%
113,329
-600
-0.5% -$5.68K
2019 Q4
19 quarters
XBI icon
109
State Street SPDR S&P Biotech ETF
XBI
$9.71B
$1.06M 0.27%
10,739
-595
-5% -$58.5K
2019 Q1
22 quarters
PCAR icon
110
PACCAR
PCAR
$56.8B
$1.06M 0.27%
10,723
+522
+5% +$51K
2022 Q2
9 quarters
NVO icon
111
Novo Nordisk
NVO
$168B
$1.06M 0.27%
8,884
+749
+9% +$99.9K
2023 Q3
4 quarters
ABT icon
112
Abbott
ABT
$178B
$1.05M 0.27%
9,174
+1
+0% +$110
2019 Q4
19 quarters
AMD icon
113
Advanced Micro Devices
AMD
$989B
$1.04M 0.27%
6,340
+1,575
+33% +$239K
2024 Q1
2 quarters
NKE icon
114
Nike
NKE
$52.5B
$1.04M 0.27%
11,698
+4,102
+54% +$322K
2016 Q4
31 quarters
RTX icon
115
RTX Corp
RTX
$247B
$1.04M 0.27%
8,560
-399
-4% -$45.5K
2022 Q2
9 quarters
BKNG icon
116
Booking.com
BKNG
$118B
$1.03M 0.26%
6,100
+3,550
+139% +$545K
2022 Q3
8 quarters
KMB icon
117
Kimberly-Clark
KMB
$32.7B
$1.03M 0.26%
7,144
+372
+5% +$52.7K
2023 Q3
4 quarters
XYZ icon
118
Block Inc
XYZ
$46.2B
$1.02M 0.26%
15,264
-40
-0.3% -$2.58K
2016 Q4
31 quarters
CART icon
119
Maplebear
CART
$11.8B
$1.02M 0.26%
25,000
-1,690
-6% -$59.3K
2024 Q1
2 quarters
MCD icon
120
McDonald's
MCD
$167B
$1.01M 0.26%
3,333
-49
-1% -$13.5K
2021 Q1
14 quarters
VNQ icon
121
Vanguard Real Estate ETF
VNQ
$36.6B
$1.01M 0.26%
10,325
– –
2020 Q4
15 quarters
VBR icon
122
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.8B
$1M 0.26%
4,989
+1,223
+32% +$235K
2023 Q2
5 quarters
MUC icon
123
BlackRock MuniHoldings California Quality Fund
MUC
$1.22B
$963K 0.25%
83,226
+3,994
+5% +$45K
2024 Q1
2 quarters
DD icon
124
DuPont de Nemours
DD
$17.5B
$958K 0.24%
8,564
+2,708
+46% +$276K
2019 Q4
19 quarters
ON icon
125
ON Semiconductor
ON
$29.9B
$936K 0.24%
12,885
+1,277
+11% +$93K
2024 Q1
2 quarters

Similar funds

Intellectus Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Intellectus Partners held 285 positions worth $391M, up 6.8% from $366M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Intellectus Partners's Q3 2024 filing shows 24 new, 110 increased, 87 reduced and 16 closed positions. Its largest new stake was Corcept Therapeutics: 54,859 shares worth $2.54M. The largest sale was KLA, an estimated $3.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Intellectus Partners's largest Q3 2024 buy was Corcept Therapeutics: 54,859 shares worth $2.54M.
  • Intellectus Partners added most to Snowflake in Q3 2024, an estimated $1.78M increase.
  • Intellectus Partners's biggest Q3 2024 reduction was KLA, cutting an estimated $3.14M.
  • Intellectus Partners fully exited Biogen in Q3 2024, selling an estimated $1.4M.
  • Intellectus Partners's ten largest holdings make up 24% of its $391M portfolio in Q3 2024.
  • Intellectus Partners opened 24 new positions and closed 16 in Q3 2024.
  • Intellectus Partners's portfolio value rose 6.8% quarter-over-quarter to $391M.

Based on Intellectus Partners's 13F filing for Q3 2024, filed 6 Nov 2024.